
1. General Information
Bosutris 400 mg Tablet contains Bosutinib 400 mg, a prescription anti-cancer medicine belonging to the tyrosine kinase inhibitor (TKI) class. It is primarily used in adults with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). Bosutinib works by inhibiting abnormal signaling proteins involved in the growth and survival of leukemia cells.
- Brand: Bosutris 400 mg
- Generic name: Bosutinib
- Strength: 400 mg
- Dosage form: Tablet
- Therapeutic class: Antineoplastic / targeted cancer therapy
- Drug class: Tyrosine kinase inhibitor
- Route: Oral
- Prescription: Prescription medicine
- Manufacturer/marketer reported for this brand: Mylan Pharmaceuticals Pvt Ltd
Bosutris should be used only under the supervision of an oncologist or other qualified healthcare professional.
2. Product Information
Bosutris 400 mg contains bosutinib, which targets specific abnormal kinase signaling associated with leukemia. The 400 mg tablet is an oral formulation and is commonly supplied in a bottle containing 30 tablets, although packaging may vary by market.
The medicine should be stored according to the product label and kept out of reach of children. The prescribing physician determines the appropriate dose and duration based on the patient's disease, treatment history, response and tolerability.
3. Uses of Bosutris 400 mg
Bosutris 400 mg is primarily used for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in adults. It may be used in different phases of CML according to the approved indication and the patient's previous treatment history.
Bosutinib may be prescribed particularly when previous treatment has been ineffective or not tolerated, depending on the clinical situation and local prescribing guidance.
4. Benefits of Bosutris 400 mg
The principal therapeutic benefit of bosutinib is its ability to inhibit abnormal kinase signaling involved in the growth and multiplication of leukemia cells.
For appropriate patients with Ph+ CML, treatment can help:
- Control abnormal leukemia-cell growth
- Reduce disease activity
- Slow progression of CML
- Help achieve and maintain appropriate treatment responses when prescribed according to the patient's clinical circumstances
Treatment response should be assessed through appropriate medical examinations and laboratory monitoring.
5. Side Effects of Bosutris 400 mg
Like other anti-cancer medicines, Bosutris can cause adverse effects. The severity and frequency can vary between patients.
Reported adverse effects include:
- Diarrhea
- Nausea
- Vomiting
- Abdominal pain
- Headache
- Cough
- Fatigue
- Breathlessness
- Decreased platelet count
- Decreased white blood cell count
- Anemia
- Increased liver enzymes
- Respiratory infections
- Nasopharyngitis
- Rash
Some adverse reactions can be serious, so patients should remain under regular medical supervision.
6. Common Side Effects
Some commonly reported side effects include:
- Diarrhea
- Nausea
- Vomiting
- Abdominal pain
- Headache
- Cough
- Fatigue
- Respiratory tract infection
- Nasopharyngitis
- Low platelet count
- Anemia
- Reduced white blood cell count
- Increased liver enzymes
- Breathlessness
Persistent, severe or unusual symptoms should be reported to the treating doctor.
7. How to Use Bosutris 400 mg
Bosutris 400 mg should be taken exactly as prescribed by the treating physician.
General administration guidance includes:
- Take the tablet according to your prescribed schedule.
- Swallow the tablet whole with water.
- Do not crush, chew or break the tablet unless specifically instructed by your healthcare professional.
- Take it consistently at the prescribed time.
- Follow your oncologist's instructions regarding whether it should be taken with food.
- Do not discontinue treatment without medical advice.
- If you miss a dose, follow the instructions provided by your doctor or pharmacist rather than taking an extra dose.
The appropriate dose can vary depending on the indication, previous treatment, response, side effects and liver or kidney function.
8. How Bosutris 400 mg Works
Bosutris contains bosutinib, a tyrosine kinase inhibitor.
In Ph+ CML, abnormal BCR-ABL signaling promotes uncontrolled growth of leukemia cells. Bosutinib inhibits this abnormal kinase signaling and other related kinases, thereby interfering with signals that support cancer-cell growth and survival.
This targeted mechanism helps slow the multiplication and progression of leukemia cells.
9. Safety Advice
Bosutris is a prescription oncology medicine and should be used under specialist supervision.
Pregnancy
Bosutinib can cause fetal harm. Women who are pregnant or planning pregnancy should discuss the treatment with their doctor before starting therapy. Appropriate contraception should be discussed with the treating healthcare professional.
Breastfeeding
Breastfeeding is generally not recommended during treatment with bosutinib; discuss this with the treating physician.
Liver problems
Tell your doctor about existing liver disease. Liver-function monitoring may be required during treatment.
Kidney problems
Inform your doctor if you have kidney disease because dosage or monitoring may need adjustment.
Blood counts
Bosutinib can affect blood-cell counts, including platelets, red blood cells and white blood cells. Regular blood tests may therefore be required.
Diarrhea and dehydration
Diarrhea can occur during treatment. Persistent or severe diarrhea should be reported to your doctor because dehydration and electrolyte disturbances can become serious.
Drug interactions
Tell your doctor or pharmacist about all prescription medicines, OTC medicines, supplements and herbal products you use. Some medicines can alter bosutinib exposure or increase the risk of adverse effects.
Important warning
Seek prompt medical attention for severe or persistent diarrhea, unusual bleeding or bruising, severe abdominal symptoms, breathing difficulties, significant swelling, severe rash, or other concerning symptoms.
10. Frequently Asked Questions (FAQs)
Q1. What is Bosutris 400 mg?
Bosutris 400 mg is a prescription anti-cancer tablet containing bosutinib 400 mg, a tyrosine kinase inhibitor.
Q2. What is Bosutris 400 mg used for?
It is primarily used for Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in adults.
Q3. Is Bosutris 400 mg a chemotherapy medicine?
It is an oral targeted anti-cancer therapy classified as a tyrosine kinase inhibitor rather than conventional cytotoxic chemotherapy.
Q4. How does Bosutris work?
It blocks abnormal kinase signaling, including BCR-ABL-related signaling, which helps inhibit the growth and survival of leukemia cells.
Q5. Can I take Bosutris without a prescription?
No. It is a prescription cancer medicine and should be used only under appropriate medical supervision.
Q6. What are the common side effects?
Diarrhea, nausea, vomiting, abdominal pain, headache, cough, fatigue, changes in blood counts and increased liver enzymes are among reported adverse effects.
Q7. Can Bosutris be taken during pregnancy?
Bosutinib may harm a developing fetus. Patients who are pregnant or planning pregnancy should consult their doctor before treatment.
Q8. Can I stop Bosutris when I feel better?
Do not stop the medicine on your own. Treatment duration should be determined by your oncologist.
Q9. Does Bosutris require regular blood tests?
Yes. Doctors may monitor blood counts, liver function and other parameters during treatment.
Q10. Can Bosutris interact with other medicines?
Yes. Several medicines can affect bosutinib levels or increase adverse-effect risks. Always provide your doctor with a complete medication list.
Q11. Can Bosutris 400 mg be substituted with another brand?
A substitute containing the same active ingredient and strength may be available, but any substitution should be confirmed by the prescribing physician or pharmacist.
Q12. Who should prescribe Bosutris?
It should be prescribed and monitored by an appropriately qualified healthcare professional, generally an oncologist or hematologist.
11. Substitute for Bosutris 400 mg
Substitution should not be based on brand name or price alone. The replacement should be checked for the same active ingredient, strength and dosage form and approved for the patient's indication.
Examples of products reported as containing bosutinib 400 mg include:
- Bosutris 400 mg – Bosutinib 400 mg
- Bonitar 400 mg – Bosutinib 400 mg
- Bosuvi 400 mg – Bosutinib 400 mg
Available brands and regulatory approvals can differ between countries. A doctor or pharmacist should confirm the appropriate substitute before any switch.
12. SEO Keywords
Primary Keywords
- Bosutris 400 mg Tablet
- Bosutris 400 mg Bosutinib Tablet
- Bosutinib 400 mg Tablet
- Bosutris 400 mg supplier
- Bosutris 400 mg exporter
- Bosutris 400 mg pharmaceutical exporter
- Bosutinib 400 mg medicine exporter
- Bosutris 400 mg wholesale supplier
- Bosutris 400 mg wholesale exporter
- Bosutinib tablets exporter from India
Long-Tail B2B Keywords
- Bosutris 400 mg Tablet exporter from Nagpur India
- Bosutinib 400 mg Tablet supplier from India
- Bosutris 400 mg pharmaceutical supplier India
- Bosutris 400 mg wholesale medicine exporter
- Bosutinib 400 mg oncology medicine exporter India
- Bosutris 400 mg anti cancer medicine supplier
- Bosutris 400 mg CML medicine exporter
- Bosutinib 400 mg CML treatment medicine supplier
- Buy Bosutris 400 mg from Indian pharmaceutical exporter
- Bosutris 400 mg international pharmaceutical supplier
- Bosutinib 400 mg bulk pharmaceutical supplier India
- Bosutris 400 mg medicine export supplier Nagpur
- Bosutris 400 mg supplier for international markets
- Bosutinib 400 mg tablets wholesale supplier
- Bosutris 400 mg oncology tablets exporter India
- Bosutris 400 mg supplier USA
- Bosutris 400 mg supplier UK
- Bosutris 400 mg supplier Australia
- Bosutris 400 mg supplier Singapore
- Bosutris 400 mg supplier Canada
- Bosutris 400 mg supplier South Korea
- Bosutris 400 mg supplier UAE
- Bosutinib 400 mg exporter to USA
- Bosutinib 400 mg exporter to UK
- Bosutinib 400 mg exporter to Australia
- Bosutinib 400 mg exporter to Singapore
- Bosutinib 400 mg exporter to Canada
- Bosutinib 400 mg exporter to South Korea
- Bosutinib 400 mg exporter to UAE
Keywords







